Analyst firms · Citizens JMP · ENTA
Citizens JMP ENTA price target and rating history
Enanta Pharmaceuticals Inc. (ENTA) · Health Care
Citizens JMP rates Enanta Pharmaceuticals Inc. (ENTA) Market Outperform with a $116 price target, as of its latest action on Nov 23, 2021. It has published 5 rating actions on ENTA since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Market Outperform
- Price target
- $116
- Median target, all firms
- Too few
- Actions on ENTA
- 5
Citizens JMP price target on ENTA
Every Citizens JMP rating on ENTA
- Nov 23, 2021
- Nov 19, 2021
- Nov 8, 2021
- Oct 20, 2021
- Aug 6, 2021
Questions about Citizens JMP and ENTA
- What is Citizens JMP's price target for ENTA?
- Citizens JMP's latest stated price target for Enanta Pharmaceuticals Inc. (ENTA) is $116, from its action on Nov 23, 2021.
- What is Citizens JMP's rating on ENTA?
- Citizens JMP rates ENTA Market Outperform, a bullish rating, as of Nov 23, 2021.
- When did Citizens JMP last change its view on ENTA?
- On Nov 23, 2021, Citizens JMP raises its price target to $116 from $111, keeps Market Outperform.
More ENTA rating histories
All Citizens JMP ratingsENTA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.